デジタルマンモグラフィ市場 - 世界の産業規模、シェア、動向、機会、予測、製品別、エンドユーザー別、地域別、競合別、2020年～2030年

デジタルマンモグラフィの世界市場規模は2024年に11億2,000万米ドルとなり、予測期間では2030年までCAGR9.39%で堅調な成長が予測されています。

世界のデジタルマンモグラフィ市場は近年大きな成長と変貌を遂げ、乳がん診断の展望に革命をもたらしています。最先端の画像技術であるデジタルマンモグラフィは、従来のフィルムベースのマンモグラフィに取って代わり、優れた画質、診断精度の向上、合理化されたワークフローを提供しています。デジタルマンモグラフィの市場拡大は、世界の乳がん罹患率の上昇、意識の向上、早期発見への取り組みが主な要因となっています。デジタルマンモグラフィは、腫瘍や石灰化を含む乳房の異常をより高い感度と特異性で検出することを容易にし、転帰の改善と死亡率の低下につながります。

デジタルマンモグラフィの技術的進歩が市場の進化に重要な役割を果たしました。フルフィールドデジタルマンモグラフィ（FFDM）やデジタルブレストトモシンセシス（DBT）といった技術革新が脚光を浴び、乳房組織のより包括的で詳細なビューを提供する3次元画像処理機能を提供するようになりました。これは、従来の2次元マンモグラフィの限界を克服する上で、特に乳腺組織が密な症例において有益であることが証明されています。人工知能（AI）と機械学習アルゴリズムの統合は、マンモグラフィ画像の解釈において放射線科医を支援することで診断精度をさらに高め、偽陽性を減らし、効率を高めています。

主要な市場促進要因

乳がんの有病率の増加

主要な市場課題

高い初期費用と経済的制約

主要な市場動向

3Dマンモグラフィ（デジタルブレストトモシンセシス）の台頭

目次

第1章 製品概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界のデジタルマンモグラフィ市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品別（2Dフルフィールドデジタルマンモグラフィトモシンセシス、3Dフルフィールドデジタルマンモグラフィトモシンセシス）
  • エンドユーザー別（病院、外来手術センター、その他のエンドユーザー）
  • 地域別
  • 企業別（2024年）
• 市場マップ
  • 製品別
  • エンドユーザー別
  • 地域別

第5章 アジア太平洋のデジタルマンモグラフィ市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品別
  • エンドユーザー別
  • 国別
• アジア太平洋：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第6章 欧州のデジタルマンモグラフィ市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第7章 北米のデジタルマンモグラフィ市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第8章 南米のデジタルマンモグラフィ市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第9章 中東・アフリカのデジタルマンモグラフィ市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • エジプト

第10章 市場力学

• 促進要因
• 課題

第11章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第12章 世界のデジタルマンモグラフィ市場：SWOT分析

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Hologic Inc .
• GE Healthcare
• Koninklijke Philips NV
• Siemens Healthcare GmBH
• Fujifilm Corporation
• Planmed Oy
• Toshiba Medical Systems
• Metaltronica S.p.A

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Digital Mammography Market was valued at USD 1.12 billion in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 9.39% through 2030. The Global Digital Mammography Market has experienced significant growth and transformation in recent years, revolutionizing the landscape of breast cancer diagnostics. Digital mammography, a state-of-the-art imaging technology, has replaced traditional film-based mammography, offering superior image quality, enhanced diagnostic accuracy, and streamlined workflow. The market's expansion is primarily driven by the rising prevalence of breast cancer worldwide, coupled with increasing awareness and early detection initiatives. Digital mammography facilitates the detection of breast abnormalities, including tumors and calcifications, with greater sensitivity and specificity, leading to improved outcomes and reduced mortality rates.

Technological advancements in digital mammography have played a pivotal role in market evolution. Innovations such as full-field digital mammography (FFDM) and digital breast tomosynthesis (DBT) have gained prominence, providing three-dimensional imaging capabilities that offer a more comprehensive and detailed view of breast tissue. This has proven particularly beneficial in overcoming the limitations of conventional two-dimensional mammography, especially in cases involving dense breast tissue. The integration of artificial intelligence (AI) and machine learning algorithms has further augmented the diagnostic accuracy by assisting radiologists in the interpretation of mammographic images, reducing false positives and enhancing efficiency.

Key Market Drivers

Increasing Prevalence of Breast Cancer

The increasing prevalence of breast cancer has become a driving force behind the growth of the global digital mammography market. Breast cancer remains one of the most common cancers globally, affecting millions of women each year. As awareness campaigns and early detection initiatives gain momentum, the demand for advanced diagnostic technologies such as digital mammography is on the rise. Digital mammography offers several advantages over traditional film-based mammography, including improved image quality, faster image acquisition, and the ability to manipulate and store digital images efficiently. These advantages are crucial in the early detection of breast cancer, enabling healthcare professionals to identify abnormalities with greater precision. Breast cancer is 1.7 times more prevalent in women over 65 compared to those aged 45-64 and 10 times more common than in women under 45. According to an NCBI research article, breast cancer incidence increases with age, ranging from 1.5 cases per 100,000 in women aged 20-24 to 421.3 cases per 100,000 in women aged 75-79. Notably, 95% of new cases occur in women aged 40 and older. The relative survival rates for breast cancer decline with age. Consequently, the growing geriatric population is anticipated to drive market growth during the forecast period.

Key Market Challenges

High Initial Costs and Economic Constraints

The Global Digital Mammography Market, while experiencing significant growth, grapples with a formidable challenge - the high initial costs and economic constraints associated with adopting advanced digital mammography technologies. The deployment of state-of-the-art digital mammography systems requires a substantial upfront investment, posing a barrier to accessibility, particularly in resource-constrained healthcare settings.

The technology involves cutting-edge imaging systems, often accompanied by advanced software for image processing and analysis. While these innovations contribute to superior diagnostic accuracy and improved patient outcomes, they come at a considerable price. Healthcare institutions, especially those in developing regions, often face budgetary constraints that make it challenging to allocate funds for such high-cost investments.

Key Market Trends

Rise of 3D Mammography (Digital Breast Tomosynthesis)

The rise of 3D mammography, also known as digital breast tomosynthesis (DBT), has emerged as a transformative force propelling the global digital mammography market to new heights. Digital breast tomosynthesis represents a significant advancement over traditional 2D mammography by providing a three-dimensional view of the breast tissue. This revolutionary technology allows radiologists to examine the breast in multiple thin slices, offering a more detailed and comprehensive assessment of abnormalities. As breast cancer detection and diagnosis become increasingly sophisticated, the demand for 3D mammography has surged, driven by its ability to improve the accuracy of breast cancer screenings.

One of the key factors contributing to the growth of the global digital mammography market is the enhanced diagnostic capabilities offered by 3D mammography. This technology reduces the limitations associated with overlapping breast tissue in traditional 2D mammography, leading to a reduction in false positives and false negatives. The improved accuracy translates to better-informed clinical decisions, ensuring that potential abnormalities are identified more precisely. As a result, 3D mammography is becoming the standard of care in breast cancer screening, further driving its adoption and contributing to the overall expansion of the digital mammography market.

Key Market Players

• Hologic Inc
• GE Healthcare
• Koninklijke Philips NV
• Siemens Healthcare GmBH
• Fujifilm Corporation
• Planmed Oy
• Toshiba Medical Systems
• Metaltronica S.p.A

Report Scope:

In this report, the Global Digital Mammography Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Digital Mammography Market, By Product:

• 2D Full Field Digital Mammography Tomosynthesis
• 3D Full Field Digital Mammography Tomosynthesis

Digital Mammography Market, By End-User:

• Hospitals
• Ambulatory Surgical Centers
• Other End-Users

Digital Mammography Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Digital Mammography Market.

Available Customizations:

Global Digital Mammography Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Digital Mammography Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Product (2D Full Field Digital Mammography Tomosynthesis, 3D Full Field Digital Mammography Tomosynthesis)
  • 4.2.2. By End-User (Hospitals, Ambulatory Surgical Centers, Other End-Users)
  • 4.2.3. By Region
  • 4.2.4. By Company (2024)
• 4.3. Market Map
  • 4.3.1. By Product
  • 4.3.2. By End-User
  • 4.3.3. By Region

5. Asia Pacific Digital Mammography Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product
  • 5.2.2. By End-User
  • 5.2.3. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Digital Mammography Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Product
      • 5.3.1.2.2. By End-User
  • 5.3.2. India Digital Mammography Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Product
      • 5.3.2.2.2. By End-User
  • 5.3.3. Australia Digital Mammography Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Product
      • 5.3.3.2.2. By End-User
  • 5.3.4. Japan Digital Mammography Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Product
      • 5.3.4.2.2. By End-User
  • 5.3.5. South Korea Digital Mammography Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Product
      • 5.3.5.2.2. By End-User

6. Europe Digital Mammography Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By End-User
  • 6.2.3. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Digital Mammography Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By End-User
  • 6.3.2. Germany Digital Mammography Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By End-User
  • 6.3.3. Spain Digital Mammography Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By End-User
  • 6.3.4. Italy Digital Mammography Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Product
      • 6.3.4.2.2. By End-User
  • 6.3.5. United Kingdom Digital Mammography Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Product
      • 6.3.5.2.2. By End-User

7. North America Digital Mammography Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By End-User
  • 7.2.3. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Digital Mammography Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By End-User
  • 7.3.2. Mexico Digital Mammography Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By End-User
  • 7.3.3. Canada Digital Mammography Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By End-User

8. South America Digital Mammography Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By End-User
  • 8.2.3. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Digital Mammography Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By End-User
  • 8.3.2. Argentina Digital Mammography Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By End-User
  • 8.3.3. Colombia Digital Mammography Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By End-User

9. Middle East and Africa Digital Mammography Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By End-User
  • 9.2.3. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Digital Mammography Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By End-User
  • 9.3.2. Saudi Arabia Digital Mammography Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By End-User
  • 9.3.3. UAE Digital Mammography Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By End-User
  • 9.3.4. Egypt Digital Mammography Market Outlook
    • 9.3.4.1. Market Size & Forecast
      • 9.3.4.1.1. By Value
    • 9.3.4.2. Market Share & Forecast
      • 9.3.4.2.1. By Product
      • 9.3.4.2.2. By End-User

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Digital Mammography Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. Hologic Inc .
  • 14.1.1. Company Snapshot
  • 14.1.2. Products & Services
  • 14.1.3. Current Capacity Analysis
  • 14.1.4. Financials (In case of listed)
  • 14.1.5. Recent Developments
  • 14.1.6. SWOT Analysis
• 14.2. GE Healthcare
• 14.3. Koninklijke Philips NV
• 14.4. Siemens Healthcare GmBH
• 14.5. Fujifilm Corporation
• 14.6. Planmed Oy
• 14.7. Toshiba Medical Systems
• 14.8. Metaltronica S.p.A

15. Strategic Recommendations

16. About Us & Disclaimer